Fingolimod
ArticlesMedicine Compliance Aid StabilityLactation Safety Information · Published , updated
18750111000001103
Articles
21 September 2020
Safety in Lactation: Other immunomodulating drugs
Several drugs in this section (dimethyl fumerate, interferon beta, fingolimod, glatiramer, natalizumab) are used in multiple sclerosis (MS) but are not normally interchangeable as they… Bacillus Calmette-Guerin Canakinumab Dimethyl fumarate Fingolimod Glatiramer Interferon alfa Lenalidomide Natalizumab Peginterferon alfa-2aMedicine Compliance Aid Stability
GilenyaNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Gilenya
Capsules 500 micrograms
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Store in airtight container and protect from moisture.
18 September 2015
Lactation Safety Information
Natalizumab
Low levels anticipated in milk due to the drug's properties
No published evidence of safety
Serious adverse effects reported in adults
22 September 2020